Quinine localizes to a non-acidic compartment within the food vacuole of the malaria parasite Plasmodium falciparum
© Bohorquez et al.; licensee BioMed Central Ltd. 2012
Received: 14 May 2012
Accepted: 18 October 2012
Published: 22 October 2012
The naturally fluorescent compound quinine has long been used to treat malaria infections. Although some evidence suggests that quinine acts in the parasite food vacuole, the mechanism of action of quinine has not yet been resolved. The Plasmodium falciparum multidrug resistance (pfmdr1) gene encodes a food vacuolar membrane transporter and has been linked with parasite resistance to quinine. The effect of multiple pfmdr1 copies on the subcellular localization of quinine was explored.
Fluorescence microscopy was used to evaluate the subcellular localization of quinine in parasites containing different pfmdr1 copy numbers to determine if copy number of the gene affects drug localization. The acidotropic dye LysoTracker Red was used to label the parasite food vacuole. Time-lapse images were taken to determine quinine localization over time following quinine exposure.
Regardless of pfmdr1 copy number, quinine overlapped with haemozoin but did not colocalize with LysoTracker Red, which labeled the acidic parasite food vacuole.
Quinine localizes to a non-acidic compartment within the food vacuole possibly haemozoin. Pfmdr1 copy number does not affect quinine subcellular localization.
KeywordsQuinine Plasmodium falciparum Pfmdr1 Copy number
Quinine (QN) was isolated from the bark of the Peruvian Cinchona tree in the mid-1800s  and quickly became the treatment of choice for intermittent fever worldwide . Although efficacious, QN use as an anti-malarial requires a relatively long treatment regimen and has substantial side effects. As a result, artemisinin-based combination therapy (ACT) has now been implemented as first-line treatment regimens due to drug efficacy and better patient tolerance. However, QN remains an important treatment option for severe malaria infections [3–5]. Despite the longevity of its use as an anti-malarial, the mechanism of action of QN has not yet been fully resolved.
Early investigations into the anti-malarial activity of QN demonstrated the ability to inhibit chloroquine-induced clumping of haemozoin in the parasite food vacuole . Subsequent evidence found that, like chloroquine, QN interferes with haem crystallization [7, 8], indicating that QN acts in the food vacuole. In recent years, parasite resistance to QN has been reported in Africa and Southeast Asia, prompting investigations into resistance mechanisms with a focus on the food vacuole [4, 9–13]. Decreased QN sensitivity has been strongly linked to a protein on the food vacuolar membrane, encoded by the Plasmodium falciparum multidrug resistance (pfmdr1) gene [10–12, 14–16]. Whereas some studies have found that pfmdr1 mutations exert a significant effect on in vitro QN sensitivity [10, 13, 14], other studies have found no association between pfmdr1 mutations and QN sensitivity [17–19]. Elevated pfmdr1 gene copy number, however, has been linked to reduced parasite susceptibility to QN in both in vitro and clinical studies [12, 16, 18–20]. Thus, pfmdr1 has an effect on quinine activity.
Quinine is an aromatic alkaloid that naturally fluoresces under ultraviolet (UV) light. Because of its relatively constant fluorescence quantum yield, QN is commonly used in photochemistry as a fluorescence standard . Surprisingly, the inherent fluorescence of QN has not previously been exploited to investigate its mechanism of action. In this study, the fluorescent properties of QN were exploited to evaluate subcellular localization of the drug by fluorescence microscopy in parasites containing different pfmdr1 copy numbers in order to determine if copy number of the gene affects drug localization.
Plasmodium falciparum cultures of two clonal parasite strains (3D7 and Dd2) with different pfmdr1 copy numbers and quinine (QN) sensitivity were used in this study. The 3D7 strain has one pfmdr1 copy and is sensitive to QN. The Dd2 strain has four pfmdr1 copies  and is resistant to QN. Cultures were maintained in candle jars at 37°C under the Trager and Jensen method for malaria parasite culturing . Media was changed every 24 hours. Type O+ serum at 10% and red blood cells (Research Blood Components, LLC: Boston, MA, USA) at 2% haematocrit in malaria culture media (MCM)  were used in culturing and experimental conditions.
Imaging of parasites using fluorescence microscopy
Live asynchronous cultures at 5-8% parasitaemia with 1μM of QN were imaged over an 11-hour period using fluorescence microscopy. Parasitized RBC preparations were plated onto 35mm glass bottom dishes (MatTek, Corp.: Ashland, MA, USA) coated with Poly-L-lysine. A coverslip was carefully applied, and the excess fluid gently squeezed out. The coverslip was sealed with warmed Vaseline to prevent the sample from drying out. Time-lapse imaging of multiple parasites was carried out with a Prior Scientific (Prior Scientific: Rockland, MA, USA) motorized x-y stage. An incubator box maintained the microscope work area including the objective at 37°C. Because P. falciparum grows well at 3% oxygen but will tolerate levels as low as 0.5% , air was in the incubator box, and the samples were sealed during imaging as stated above. LysoTracker Red DND-99 (Invitrogen: Carlsbad, CA, USA) (50nM) was used to stain the food vacuole and DRAQ5 (Biostatus Limited: Leicestershire, UK) (1μM) was used to stain DNA . Fluorescence images were acquired using an Olympus FV1000 inverted IX81 microscope with a 63x 1.42 NA oil immersion objective at the UNC-Chapel Hill Michael Hooker Microscopy Core Facility. Serial sections with step sizes of 0.20 or 0.25μm were gathered using sequential scanning at 405nm (QN), 559nm (LysoTracker Red), and 635nm (DRAQ5) excitation, and 435±25nm, 595±25nm and 705±50nm emission filters for QN, LysoTracker Red, and DRAQ5 respectively. Confocal pinhole was set to maximum (800μm, ~8 Airy units). Laser transmitted light differential interference contrast (DIC) images were collected at an optimum z-level separately. Image stacks were deconvolved using the iterative blind deconvolution method with Volocity Image Analysis software, version 5.52 (Perkin Elmer: Waltham, MA, USA). Occasionally, Tetraspec 0.1μm beads (Molecular Probes, OR) were added to the sample and used for deconvolution with measured point spread functions. Three-dimensional (3-D) opacity volume rendering and 3-D co-localization analysis was carried out with Volocity.
Quinine localizes to the parasite food vacuole
Although QN was the first therapeutic compound used to treat malaria infection , its mechanism of action has never been fully resolved [6–8]. Some evidence suggests that parasite resistance to QN is associated with mutations and/or elevated copy number of the pfmdr1 gene, which encodes for a transporter protein found in the membrane of the parasite food vacuole [9, 10, 12–14, 16, 18, 20]. Here, the natural fluorescent properties of QN were exploited to obtain insight into the mechanism of action of the drug. Although knowledge of QN’s fluorescent properties has been around since the late-1800s , this is the first study to employ the QN’s fluorescence for imaging in the malaria parasite.
Fluorescence microscopy was employed to image QN subcellular localization in two P. falciparum strains that contained different pfmdr1 copy numbers. Quinine consistently overlapped with the haemozoin crystals in both strains when evaluated by 2-D microscopy (Figure 1). However, upon 3-D reconstruction of serial z-stack images, QN was found to reside in a distinct compartment, which is contiguous to, but separate from, the compartment stained by LysoTracker Red. The lack of co-localization with the acidotropic dye suggests that QN resides in a non-acidic compartment within the food vacuole, possibly the same one occupied by haemozoin. This would be consistent with previous reports that quinolone compounds including QN interact with haemozoin crystals directly or with enzymes involved in the haemozoin crystallization process, as previously reported [7, 8, 29–33]. In summary, these findings suggest that QN is localized in a non-acidic compartment in the food vacuole, possibly that which contains haemozoin.
This study underscores the importance of utilizing the 3-D reconstruction software in imaging studies, since the localization of QN into this novel compartment would not have been detected otherwise. A recent study revealed that QN-haem adducts exhibit fluorescence at least seven-fold greater than QN alone . Thus, it is possible that QN exists in other areas of the food vacuole but cannot be visualized due to the fluorescence intensity of the QN-haem adducts present in these parasites.
Although there was no apparent difference in localization in strains containing different pfmdr1 copy numbers, the possibility that the pfmdr1 gene has a role cannot be ruled out. Single nucleotide polymorphisms in pfmdr1 have also been associated with decreased sensitivity to QN [10, 13, 14]. Because the protein encoded by pfmdr1 is a membrane transporter that pumps solutes into the food vacuole, it is possible that mutations within the pfmdr1 gene could affect the transporter function of the protein by altering the conformation or function of the transporter protein.
In summary, this study is novel because it is the first to exploit quinine fluorescence to study the intracellular distribution of the drug. Here, QN was shown to enter a distinct, non-acidic compartment inside the parasite food vacuole. These results are important because they provide visual support for the hypothesis that QN interferes with haemozoin production, which could guide future studies to investigate a possible interaction between QN and enzymes involved in the haemozoin formation process.
Quinine localizes to a non-acidic compartment within the food vacuole and pfmdr1 copy number does not affect QN subcellular localization. These results support previous findings that QN acts in the parasite food vacuole, perhaps interfering with haemozoin formation. This is the first study to provide evidence for QN localization in a sub-compartment of the food vacuole.
Funding for this project was provided by NIH grant 1-R21-AI076785-01A1.
- Bruce-Chwatt LJ: Three hundred and fifty years of the peruvian fever bark. Br Med J (Clin Res Ed). 1988, 296: 1486-1487. 10.1136/bmj.296.6635.1486.View ArticleGoogle Scholar
- Yeka A, Achan J, D'Alessandro U, Talisuna AO: Quinine monotherapy for treating uncomplicated malaria in the era of artemisinin-based combination therapy: an appropriate public health policy?. Lancet Infect Dis. 2009, 9: 448-452. 10.1016/S1473-3099(09)70109-4.View ArticlePubMedGoogle Scholar
- WHO: World malaria report. 2010, World Health Organization, GenevaGoogle Scholar
- Okombo J, Ohuma E, Picot S, Nzila A: Update on genetic markers of quinine resistance in Plasmodium falciparum. Mol Biochem Parasitol. 2011, 177: 77-82. 10.1016/j.molbiopara.2011.01.012.View ArticlePubMedGoogle Scholar
- Kyu HH, Fernandez E: Artemisinin derivatives versus quinine for cerebral malaria in african children: a systematic review. Bull World Health Organ. 2009, 87: 896-904. 10.2471/BLT.08.060327.PubMed CentralView ArticlePubMedGoogle Scholar
- Peters W: Antimalarial drugs and their actions. Postgrad Med J. 1973, 49: 573-583. 10.1136/pgmj.49.574.573.PubMed CentralView ArticlePubMedGoogle Scholar
- Slater AF, Cerami A: Inhibition by chloroquine of a novel haem polymerase enzyme activity in malaria trophozoites. Nature. 1992, 355: 167-169. 10.1038/355167a0.View ArticlePubMedGoogle Scholar
- Egan TJ, Ross DC, Adams PA: Quinoline anti-malarial drugs inhibit spontaneous formation of beta-haematin (malaria pigment). FEBS Lett. 1994, 352: 54-57. 10.1016/0014-5793(94)00921-X.View ArticlePubMedGoogle Scholar
- Zalis MG, Pang L, Silveira MS, Milhous WK, Wirth DF: Characterization of Plasmodium falciparum isolated from the Amazon region of Brazil: evidence for quinine resistance. Am J Trop Med Hyg. 1998, 58: 630-637.PubMedGoogle Scholar
- Sidhu AB, Valderramos SG, Fidock DA: pfmdr1 Mutations contribute to quinine resistance and enhance mefloquine and artemisinin sensitivity in plasmodium falciparum. Mol Microbiol. 2005, 57: 913-926. 10.1111/j.1365-2958.2005.04729.x.View ArticlePubMedGoogle Scholar
- Nkrumah LJ, Riegelhaupt PM, Moura P, Johnson DJ, Patel J, Hayton K, Ferdig MT, Wellems TE, Akabas MH, Fidock DA: Probing the multifactorial basis of plasmodium falciparum quinine resistance: evidence for a strain-specific contribution of the sodium-proton exchanger PfNHE. Mol Biochem Parasitol. 2009, 165: 122-131. 10.1016/j.molbiopara.2009.01.011.PubMed CentralView ArticlePubMedGoogle Scholar
- Sidhu AB, Uhlemann AC, Valderramos SG, Valderramos JC, Krishna S, Fidock DA: Decreasing pfmdr1 copy number in plasmodium falciparum malaria heightens susceptibility to mefloquine, lumefantrine, halofantrine, quinine, and artemisinin. J Infect Dis. 2006, 194: 528-535. 10.1086/507115.PubMed CentralView ArticlePubMedGoogle Scholar
- Reed MB, Saliba KJ, Caruana SR, Kirk K, Cowman AF: Pgh1 Modulates sensitivity and resistance to multiple antimalarials in plasmodium falciparum. Nature. 2000, 403: 906-909. 10.1038/35002615.View ArticlePubMedGoogle Scholar
- Mu J, Ferdig MT, Feng X, Joy DA, Duan J, Furuya T, Subramanian G, Aravind L, Cooper RA, Wootton JC, Xiong M, Su XZ: Multiple transporters associated with malaria parasite responses to chloroquine and quinine. Mol Microbiol. 2003, 49: 977-989. 10.1046/j.1365-2958.2003.03627.x.View ArticlePubMedGoogle Scholar
- Cowman AF, Galatis D, Thompson JK: Selection for mefloquine resistance in Plasmodium falciparum is linked to amplification of the pfmdr1 gene and cross-resistance to halofantrine and quinine. Proc Natl Acad Sci U S A. 1994, 91: 1143-1147. 10.1073/pnas.91.3.1143.PubMed CentralView ArticlePubMedGoogle Scholar
- Chaijaroenkul W, Wisedpanichkij R, Na-Bangchang K: Monitoring of in vitro susceptibilities and molecular markers of resistance of plasmodium falciparum isolates from thai-myanmar border to chloroquine, quinine, mefloquine and artesunate. Acta Trop. 2010, 113: 190-194. 10.1016/j.actatropica.2009.10.016.View ArticlePubMedGoogle Scholar
- Price RN, Uhlemann AC, van Vugt M, Brockman A, Hutagalung R, Nair S, Nash D, Singhasivanon P, Anderson TJ, Krishna S, White NJ, Nosten F: Molecular and pharmacological determinants of the therapeutic response to artemether-lumefantrine in multidrug-resistant plasmodium falciparum malaria. Clin Infect Dis. 2006, 42: 1570-1577. 10.1086/503423.PubMed CentralView ArticlePubMedGoogle Scholar
- Price RN, Uhlemann AC, Brockman A, McGready R, Ashley E, Phaipun L, Patel R, Laing K, Looareesuwan S, White NJ, Nosten F, Krishna S: Mefloquine resistance in plasmodium falciparum and increased pfmdr1 gene copy number. Lancet. 2004, 364: 438-447. 10.1016/S0140-6736(04)16767-6.PubMed CentralView ArticlePubMedGoogle Scholar
- Pickard AL, Wongsrichanalai C, Purfield A, Kamwendo D, Emery K, Zalewski C, Kawamoto F, Miller RS, Meshnick SR: Resistance to antimalarials in southeast asia and genetic polymorphisms in pfmdr1. Antimicrob Agents Chemother. 2003, 47: 2418-2423. 10.1128/AAC.47.8.2418-2423.2003.PubMed CentralView ArticlePubMedGoogle Scholar
- Anderson TJ, Nair S, Qin H, Singlam S, Brockman A, Paiphun L, Nosten F: Are transporter genes other than the chloroquine resistance locus (pfcrt) and multidrug resistance gene (pfmdr) associated with antimalarial drug resistance?. Antimicrob Agents Chemother. 2005, 49: 2180-2188. 10.1128/AAC.49.6.2180-2188.2005.PubMed CentralView ArticlePubMedGoogle Scholar
- Fletcher AN: Quinine sulfate as a fluorescence quantum yield standard. Photochem Photobiol. 1969, 9: 439-444. 10.1111/j.1751-1097.1969.tb07311.x.View ArticlePubMedGoogle Scholar
- Lim P, Alker AP, Khim N, Shah NK, Incardona S, Doung S, Yi P, Bouth DM, Bouchier C, Puijalon OM, Meshnick SR, Wongsrichanalai C, Fandeur T, Le Bras J, Ringwald P, Ariey F: Pfmdr1 copy number and arteminisin derivatives combination therapy failure in falciparum malaria in Cambodia. Malar J. 2009, 8: 11-10.1186/1475-2875-8-11.PubMed CentralView ArticlePubMedGoogle Scholar
- Trager W, Jensen JB: Cultivation of malarial parasites. Nature. 1978, 273: 621-622. 10.1038/273621a0.View ArticlePubMedGoogle Scholar
- Methods in malaria research. 2008, Malaria Research and Reference Reagent Resource Center (MR4)/American Type Culture Collection (ATCC), Manassas, VAGoogle Scholar
- Scheibel LW, Adler A, Trager W: Tetraethylthiuram disulfide (antabuse) inhibits the human malaria parasite plasmodium falciparum. Proc Natl Acad Sci U S A. 1979, 76: 5303-5307. 10.1073/pnas.76.10.5303.PubMed CentralView ArticlePubMedGoogle Scholar
- Purfield AE, Tidwell RR, Meshnick SR: The diamidine DB75 targets the nucleus of plasmodium falciparum. Malar J. 2009, 8: 104-10.1186/1475-2875-8-104.PubMed CentralView ArticlePubMedGoogle Scholar
- Veiga MI, Ferreira PE, Schmidt BA, Ribacke U, Bjorkman A, Tichopad A, Gil JP: Antimalarial exposure delays plasmodium falciparum intra-erythrocytic cycle and drives drug transporter genes expression. PLoS One. 2010, 5: e12408-10.1371/journal.pone.0012408.PubMed CentralView ArticlePubMedGoogle Scholar
- Urbach F: The historical aspects of sunscreens. J Photochem Photobiol B. 2001, 64: 99-104. 10.1016/S1011-1344(01)00202-0.View ArticlePubMedGoogle Scholar
- de Villiers KA, Gildenhuys J, le Roex T: Iron(III) protoporphyrin IX complexes of the antimalarial cinchona alkaloids quinine and quinidine. ACS Chem Biol. 2012, 7: 666-671. 10.1021/cb200528z.View ArticlePubMedGoogle Scholar
- Pisciotta JM, Coppens I, Tripathi AK, Scholl PF, Shuman J, Bajad S, Shulaev V, Sullivan DJ: The role of neutral lipid nanospheres in Plasmodium falciparum haem crystallization. Biochem J. 2007, 402: 197-204. 10.1042/BJ20060986.PubMed CentralView ArticlePubMedGoogle Scholar
- Leed A, DuBay K, Ursos LM, Sears D, De Dios AC, Roepe PD: Solution structures of antimalarial drug-haem complexes. Biochemistry. 2002, 41: 10245-10255. 10.1021/bi020195i.View ArticlePubMedGoogle Scholar
- Egan TJ, Ncokazi KK: Quinoline antimalarials decrease the rate of beta-hematin formation. J Inorg Biochem. 2005, 99: 1532-1539. 10.1016/j.jinorgbio.2005.04.013.View ArticlePubMedGoogle Scholar
- Correa Soares JB, Menezes D, Vannier-Santos MA, Ferreira-Pereira A, Almeida GT, Venancio TM, Verjovski-Almeida S, Zishiri VK, Kuter D, Hunter R, Egan TJ, Oliveira MF: Interference with haemozoin formation represents an important mechanism of schistosomicidal action of antimalarial quinoline methanols. PLoS Negl Trop Dis. 2009, 3: e477-10.1371/journal.pntd.0000477.PubMed CentralView ArticlePubMedGoogle Scholar
- Alumasa JN, Gorka AP, Casabianca LB, Comstock E, de Dios AC, Roepe PD: The hydroxyl functionality and a rigid proximal N are required for forming a novel non-covalent quinine-haem complex. J Inorg Biochem. 2011, 105: 467-475. 10.1016/j.jinorgbio.2010.08.011.PubMed CentralView ArticlePubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.